🇺🇸 FDA
Patent

US 9994901

Pro-inflammatory mediators in diagnosis and treatment of chronic obstructive pulmonary disease

granted A61KA61K31/5575

Quick answer

US patent 9994901 (Pro-inflammatory mediators in diagnosis and treatment of chronic obstructive pulmonary disease) held by The Regents of the University of Colorado, a Body Corporate expires Mon Jun 07 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of Colorado, a Body Corporate
Grant date
Tue Jun 12 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 07 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K31/5575